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Current human pluripotent stem cells lack the tran-
scription factor circuitry that governs the ground
state of mouse embryonic stem cells (ESC). Here,
we report that short-term expression of two compo-
nents, NANOG and KLF2, is sufficient to ignite other
elements of the network and reset the human plurip-
otent state. Inhibition of ERK and protein kinase C
sustains a transgene-independent rewired state.
Reset cells self-renew continuously without ERK
signaling, are phenotypically stable, and are karyo-
typically intact. They differentiate in vitro and form
teratomas in vivo. Metabolism is reprogrammed
with activation of mitochondrial respiration as in
ESC. DNA methylation is dramatically reduced and
transcriptome state is globally realigned across mul-
tiple cell lines. Depletion of ground-state transcrip-
tion factors, TFCP2L1 or KLF4, has marginal impact
on conventional human pluripotent stem cells but
collapses the reset state. These findings demon-
strate feasibility of installing and propagating func-
tional control circuitry for ground-state pluripotency
in human cells.
INTRODUCTION
Human pluripotent stem cells (PSC), derived from supernumer-
ary embryos or by molecular reprogramming, show several
distinguishing characteristics compared with paradigmatic
mouse embryonic stem cells (ESC). Originally regarded as1254 Cell 158, 1254–1269, September 11, 2014 ª2014 The Authorsinconsequential species-specific features, increasing evidence
suggests discrete developmental identities. Notably, derivation
of postimplantation epiblast stem cells (EpiSC) (Brons et al.,
2007; Tesar et al., 2007) shows that alternative pluripotent
stem cells can be obtained frommice. EpiSC are related to prim-
itive streak-stage late epiblast (Kojima et al., 2014; Tsakiridis
et al., 2014). The terminology naive and primed was introduced
to describe early and late phases of epiblast ontogeny and
respective ESC and EpiSC derivatives (Nichols and Smith,
2009). Human PSC are considered more related to primed
EpiSCs than to naive ESC.
Mouse ESC self-renewal is favored by blockade of mitogen-
activated protein kinase (Erk) signaling and is stimulated by the
cytokine leukemia inhibitory factor (LIF) (Nichols and Smith,
2012). Combining two inhibitors (2i) of the Erk pathway and
of glycogen synthase kinase-3 with LIF (2iL) provides a defined
culture system that is effective for all strains of mouse and rat
tested, supporting efficient ESC derivation and clonal expansion
from dissociated cells (Boroviak et al., 2014; Ying et al., 2008).
This serum- and growth-factor-free formulation is also selective;
most cell types, including EpiSC and human PSC, differentiate or
die in 2iL alone. The stability and relative homogeneity of ESC in
2iL (Wray et al., 2010) is postulated to represent a developmental
ground state closely reflective of the newly formed epiblast in the
mature blastocyst (Nichols and Smith, 2009). In contrast, EpiSC
and human PSC are heterogeneous between and within cell
lines (Kojima et al., 2014; Tsakiridis et al., 2014) and passage
poorly when dissociated, resulting in low cloning efficiency.
They are unresponsive to LIF but rely on growth factors, specif-
ically fibroblast growth factor (FGF) and TGFb/activin (Amit et al.,
2000; Vallier et al., 2005).
The transcriptional regulators Oct4 and Sox2 constitute the
pillar of pluripotency through all its phases. These factors are
essential but are not restricted to, nor sufficient for, the ESC
ground state. A select group of regulators present in the pre-
implantation epiblast and ESC interconnect with Oct4/Sox2
to confer and sustain naive status. Foremost among these are
Nanog, Klf2, Klf4, Esrrb, and Tfcp2l1 (Dunn et al., 2014; Ivanova
et al., 2006; Martello et al., 2013; Niwa et al., 2009; Ye et al.,
2013). Apart from Nanog, these factors are expressed at very
low levels or are absent from EpiSC and human PSC. Strikingly,
however, transfection of EpiSC with a single component in
conjunction with transfer to 2iL can ignite the entire circuitry
and reset the ESC ground state (Guo et al., 2009; Hanna et al.,
2009; Silva et al., 2009).
Conversion of mouse EpiSCs to ESC may provide a paradigm
for generation of human ground-state PSC. Early trials (Hanna
et al., 2010; Wang et al., 2011) noted ESC-like morphology, but
cells appeared unstable. More recently, complex culture formu-
lations have been proposed to allow propagation of human PSC
with altered characteristics (Chan et al., 2013; Gafni et al., 2013;
Ware et al., 2014), but these cells remain dependent on FGF,
TGFb, and/or serum replacement factors and lack evidence for
rewiring of transcriptional control circuitry. We therefore investi-
gated further the generation and stabilization of human cells with
phenotypic features and transcription factor governance charac-
teristic of ground-state pluripotency.
RESULTS
NANOG and KLF2 Reset the Human PSC Phenotype
Expression of Nanog or Klf2 converts mouse EpiSC to ground-
state ESC in 2iL (Hall et al., 2009; Silva et al., 2009). We tested
the effect of this pair of factors in human embryo-derived H9
cells. We introduced doxycycline (DOX)-inducible KLF2 and
NANOG/Venus constructs along with an rtTA vector. Transfec-
tants were selected in conventional PSC culture medium (FGF/
KSR) without DOX. Cultures were replated prior to addition of
DOX. DOX-induced cells differentiated or died in FGF/KSR. In
contrast, in 2iL undifferentiated cells persisted and formed col-
onies that could readily be expanded. These cells were positive
for Venus, indicating robust transgene induction, and displayed
the tightly packed domed appearance typical of mouse ESC in
2iL (Figure 1A). Cultures could be propagated continuously by
enzymatic dissociation to single cells without requirement for
ROCKi (Watanabe et al., 2007). On withdrawal of DOX, however,
cultures degenerated unless transferred into FGF/KSR when
they reverted to conventional flat PSC colony morphology and
sensitivity to dissociation. Cells could be cycled between these
two exclusive conditions (Figure 1A).
We investigated candidate pathways for the ability to support
propagation in 2iL upon DOX withdrawal. Addition of the protein
kinase C (PKC) inhibitor Go¨6983 (5 mM), which suppresses
mouse ES cell differentiation (Dutta et al., 2011), sustained
compact refractile colonies lacking Venus (Figure 1B). These
cultures expressed OCT4 (Figure S1 available online) and
expanded continuously, although proliferation was reduced
and morphology less consistent compared to cells in DOX.
Moderating GSK3 inhibition improves rat ES cell culture (Chen
et al., 2013; Meek et al., 2013), and we also observed that
combination of Go¨6983 with GSK3 inhibitor CH is unfavorableCfor mouse ESC propagation (A.S., unpublished data). Colony
morphology in the absence of DOX was improved without CH,
but growth rate was reduced. An intermediate concentration of
1 mM CH restored growth while maintaining morphology (Fig-
ure 1C). Henceforth cells were maintained in titrated 2i with LIF
and Go¨6983 (t2iL+Go¨). Undifferentiated colonies formed from
dissociated cells without ROCKi (Figure 1D). Immunoblotting
confirmed that Erk signaling was fully blocked (Figure S1B). Col-
ony formation was not suppressed by inhibitors of TGF-b/activin
or FGF receptors (Figures 1E and S1C).
We induced conversion using different embryo-derived and
induced PSC (Table S1) and in all cases obtained abundant
tightly packed colonies with DOX. On DOX withdrawal and
switch to t2iL+Go¨, cultures initially became heterogeneous.
Tightly packed colonies dominated after two to four passages
and thereafter were readily maintained over multiple passages
by single-cell dissociation every 4–6 days and replating at a split
ratio of 1:3 to 1:5. Independent cultures were propagated for
more than 20 passages (4 months) with no deterioration in
morphology or doubling time (Figure 1F and Table S1). Meta-
phase counts and array analyses (Figure 1G and Table S1)
confirmed genetic integrity of different lines over multiple
passages.
Following DOX withdrawal, transgene products were unde-
tectable by fluorescence or qRT-PCR (Figures S1D and S1E).
We profiled cultures in t2iL+Go¨ for the suite of transcription
factors diagnostic of, and functionally implicated in, the
ESC ground state (Dunn et al., 2014). Compared with no or
minimal expression in conventional PSC, all factors were sub-
stantially upregulated apart from ESRRB (Figures 1H and
S1E). Protein expression was confirmed by immunostaining
and immunoblotting (Figures 1I, 1J, and S1F). TFE3 was nu-
clear compared with cytoplasmic localization in conventional
PSC, as shown for mouse naive versus primed cells (Bet-
schinger et al., 2013).
The preceding experiments were performed on feeders. From
observations with mouse ESC, we realized that, without buff-
ering by feeders, Go¨ was potentially toxic. We therefore reduced
Go¨ to 2 mM and also added ROCKi prior to passaging. In these
conditions, reset cells could form undifferentiated colonies on
Matrigel or laminin 511-E8 (Nakagawa et al., 2014) (Figure 1K).
On both substrates, cells could be expanded, albeit more slowly
on laminin, with retained expression of ground-state pluripo-
tency factors (Figure 1L).
These observations indicate that NANOG and KLF2 can reset
self-renewal requirements and transcription factor complement
in human PSC and, furthermore, that this rewired state may be
rendered independent of transgene expression by fine-tuning
2iL in combination with the PKC inhibitor Go¨6983.
Differentiation Competence
To test whether reset PSC are capable of germ-layer specifica-
tion, we generated embryoid bodies directly from reset cells.
Embryoid bodies were harvested after 5 or 10 days and analyzed
by qRT-PCR. Transcripts diagnostic of the three germ layers
were upregulated (Figure 2A). Differentiation capacity was tested
further by grafting to NOD/SCIDmice. Cells transplanted directly
from t2iL+Go¨ formed teratomas by 12 weeks that containedell 158, 1254–1269, September 11, 2014 ª2014 The Authors 1255
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well-differentiated regions of neuroepithelium, cartilage, and
digestive tract (Figure 2B).
On transfer to FGF/KSR, reset cells adopted a conventional
PSC phenotype (Figure 2C) accompanied by downregulation
of ground-state pluripotency factors (Figure 2D). After culture
for two passages in FGF/KSR, cells lost ability to form colonies
in t2iL+Go¨, confirming a stable change in cell state (Figure 2E).
We reasoned that reset cells could be channeled into adherent
differentiation by exposure to FGF/KSR and application of proto-
cols developed for conventional PSC. Cells exchanged into FGF/
KSR for a few days responded to activin andWnt3A (Kroon et al.,
2008) by differentiation into definitive endoderm (Figure 2F).
Conversely, treatment with Noggin and SB431542 (Chambers
et al., 2009) resulted in neuronal cells with dendritic processes
(Figure 2G). Cells changed into FGF/KSR and aggregated, upre-
gulated cardiac markers (Figure 2H), and formed outgrowths
with beating foci.
We conclude that reset cells can progress via a primed state
into germ-layer differentiation.
Mitochondrial and Metabolic Adjustment
ESC utilize oxidative phosphorylation, whereas EpiSC/human
PSC are almost entirely glycolytic with very low mitochondrial
respiration capacity (Zhou et al., 2012). We measured basal ox-
ygen consumption rate (OCR) and found that it was substantially
higher in reset cells than in conventional PSC (Figure 3A). Higher
electron transport chain activity in reset cells was evidenced by a
greater OCR increase in response to the mitochondrial uncou-
pler FCCP (Figure 3A). Reset cells also displayed intense staining
with tetramethylrhodamine methyl ester (TMRE), indicative of
mitochondrial membrane depolarization (Figure 3B). Further-
more, the complex IV cytochrome c oxidase (COX) gene family
displayed higher expression in reset cells than conventional
PSC for 14 out of 17 genes (Figure S2A), similar to findings for
ESC and EpiSC (Zhou et al., 2012).
We examined functional consequences of altered metabolic
properties by culture in 2-deoxyglucose to inhibit glycolysis
and in reduced concentrations of glucose to increase depen-
dency on mitochondrial respiration. Unlike conventional PSC,
reset cells formed undifferentiated colonies in the presenceFigure 1. Resetting Human PSC
Data in this and other figures are from H9 cells unless otherwise indicated, but s
(Table S1 and Figure S1)
(A) Induction or silencing of transgenes combined with switching between 2iL and
expression indicated by the Venus reporter.
(B) PKC inhibitor Go¨6983 maintains colony morphology in the absence of transg
signal.
(C) Expansion in different CH concentrations. Cells were plated at 5 3 104 cells
(D) Cells previously cultured in t2iL with DOX were plated in 6-wells without ROC
(E) Cells maintained in t2iL+Go¨ were seeded in 12-well dishes without ROCKi in
(F) Cell proliferation data.
(G) G-banded karyotype of reset cells at passage 16 (converted at parental pass
(H) qRT-PCR for pluripotency factor transcripts.
(I) Immunostaining for ground-state pluripotency markers. The dot in the TFCP2L
(J) Immunoblotting for ground-state pluripotency proteins in conventional and re
(K) Reset cells on Matrigel or laminin 511-E8.
(L) qRT-PCR for ground-state transcription factor transcripts in reset cells after
conventional PSC on Matrigel in mTeSR are controls.
Scale bars: (A and B) 100 mM, (I and K) 20 mM. Error bars indicate SD.
Cof 2-deoxyglucose (Figure 3C) or as low as 0.2 mM glucose
(Figure S2B).
These data indicate that resetting human PSC is accompa-
nied by a profound mitochondrial activation and metabolic
realignment.
Epigenetic Reorganization
Global DNA hypomethylation is a feature of early embryo cells
that is recapitulated in ESC cultured in 2i in contrast to hyperme-
thylation in EpiSCs (Ficz et al., 2013; Habibi et al., 2013; Leitch
et al., 2013). Immunofluorescence staining for 5-methylcytosine
(5mC) was notably weaker in reset cells than conventional cul-
tures (Figure 4A). Mass spectrometric quantification confirmed
a major reduction in total 5mC and also in 5-hydroxymethylcyto-
sine (Figure 4B). Bisulfite sequencing (BS-seq) at 8.83 genome
coverage (Figure S3A) substantiated more than 50% loss of
CpG methylation genome wide (Figure 4C), along with lower
non-CpG methylation. Demethylation was substantial in most
genomic contexts (Figure 4D). A representative genomic interval
shows hypomethylation across the SOX2 locus (Figure S3B).
A minor subset of genes showed retained or even increased
methylation.
The X chromosome in reset cells exhibited specific reduction
in intermediate levels of CGI demethylation (Figure 4E). Interme-
diate levels are likely to reflect methylation of a proportion of X-
linked CGIs in conventional PSC. Consistent with epigenetic
erasure of the X chromosome, we observed that foci of histone
3 lysine 27 trimethylation (H3K27me3) were almost entirely lack-
ing in reset XX cells (Figure 4F), although as previously described
(Silva et al., 2008; Tomoda et al., 2012), this modification was
already absent in many of the parental cells. Notably, however,
upon transfer of reset cells to KSR/FGF culture conditions, foci
of H3K27me3 appeared in the majority of cells within two pas-
sages. We also examined trimethylation of histone 3 lysine 9
(H3K9me3) associated with gene silencing. Reset cells exhibit
much lower levels of this feature compared with conventional
human PSC, recapitulating the difference observed between
mouse ESC and EpiSC (Figures 4G, S3C, and S3D).
These data indicate that resetting the human PSC state is
accompanied by profound epigenetic deconstruction. Localimilar results were obtained from H1 and Shef6 cells and various iPS cell lines
FGF/KSR supports expansion of colonies with distinct morphology. Transgene
ene expression. Intrinsic fluorescence of Go¨ produces a faint red background
per well and were cultured for 4 days in PD03 with LIF and 0, 1, or 3 mM CH.
Ki in conditions indicated and were stained after 10 days.
conditions indicated.
age 40).
1 image of reset cells is due to intrinsic fluorescence of Go¨.
set cells.
five passages on Matrigel (Ma) or Laminin511-E8 (La). Cultures on MEF and
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Figure 3. Mitochondrial Activity
(A) Oxygen consumption rate (OCR) measure-
ments.
(B) Mitochondrial staining. MitoTracker is a general
stain; TMRE staining is dependent on mitochon-
drial membrane activity. Scale bar, 10 mM; inset,
15 mM.
(C) Colony formation in 2-deoxyglucose. 3 3 104
cells were seeded in 12-well plates and were
cultured for 7 days with indicated concentrations
of 2-deoxyglucose (2DG).
Error bars indicate SD. See also Figure S2.demethylation has been described for purported human naive
PSC (Gafni et al., 2013), but no evidence has been provided for
global changes or for demethylation of the X chromosome. The
global reduction in DNA methylation in reset cells is similar in
magnitude to hypomethylation in mouse ground-state ESC and
in line with the demethylated status reported for the human inner
cell mass (ICM) (Guo et al., 2014; Smith et al., 2014).
Transcriptome Reconfiguration
We assessed the transcriptional state of conventional human
PSC, reset cells, and mouse ESC by RNA-seq. Multiple inde-
pendent conventional cultures of H9 and induced PSC were
analyzed alongside reset counterparts. Clustering by principal
component analysis revealed mutually exclusive groups of con-
ventional human PSC and reset cells, with distinct clusters of
mouse ESC and human reset cells (Figure 5A). Much of the vari-
ation (24%) is captured in the first principal component, indicating
significant correspondence between reset cells and human blas-
tocyst ICM (Yan et al., 2013). In contrast, explanted human ICM
cells propagated in FGF/KSR adopt similar expression profiles
toconventionalPSCcultures.Divergencewith respect to the sec-
ond principal component is not unexpected given that ESC bear
closest resemblance to epiblast cells in the late blastocyst rather
than immature ICM cells (Boroviak et al., 2014).
Inspection of genes contributing to the first two principal com-
ponents confirms the influence of pluripotency factors in resetFigure 2. Differentiation
(A) Expression of lineage markers in embryoid bodies formed from reset cells in KSR or serum.
(B) Teratomas formed from reset cells in three out of ten mice.
(C) Reset cells convert to conventional PSC morphology after transfer to FGF/KSR. Bottom panel shows typ
(D) Downregulation of naive markers in FGF/KSR.
(E) Colony formation after transfer of reset cells into FGF/KSR for two passages. Cells plated in the presenc
(F) Definitive endoderm differentiation in activin and Wnt. Flow cytometry and immunostaining.
(G) Neuronal differentiation after dual inhibition of activin and BMP pathways.
(H) qRT-PCR assay of cardiac lineage markers in embryoid body outgrowths.
Scale bars: (C, F, and G) 100 mM.
Cell 158, 1254–1269, Sepcells and of lineage specifiers in conven-
tional PSC (Figure S4A). Analysis of an in-
dependent panel of genes selected by the
International Stem Cell Initiative (Ade-
wumi et al., 2007) shows that reset cells
and ESC share similar patterns with
respect to upregulation of pluripotencyregulators and repression of lineage markers (Figure 5B). In
contrast to conventional PSC, robust expression was observed
of ground-state pluripotency regulators in both reset cells and
ground-state ESC. This is accompanied by repression of line-
age-specific genes. Reset cells and ESC form a distinct cluster
characterized by the robust expression of naive markers
including NANOG, KLF4, and TFCP2L1. In contrast, PSC
cultured in conventional media or the 3iL formulation (Chan
et al., 2013) show prominent expression of lineage markers
such as AFP, Brachyury, and EOMES. Gene ontology analysis
of differentially expressed genes indicated enrichment of cate-
gories representative of developmental pathways (Table S2).
We additionally compared reset and conventional PSC with
NHSM or 3iL cells purported to have undergone conversion to
a naive state (Chan et al., 2013; Gafni et al., 2013). To facilitate
direct comparison, samples were hybridized to the identical
microarray platform used in Gafni et al. (2013). We profiled an
extended panel of samples, including reset cells and standard
counterparts fromH9 and two independent iPS cell lines, in addi-
tion to those profiled by RNA-seq above. Data from each study
were normalized to conventional human embryo-derived PSC
to integrate microarray and RNA-seq data sets. A significant de-
parture from the conventional state was not apparent for cell
lines propagated in alternate culture regimes, suggesting that
they have not fundamentally changed from standard human
PSC (Figure 5A). Analysis of data from Gafni et al. (2013) revealsical colony four passages after transfer.
e of ROCKi.
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wide variation across individual lines but relatively minor diver-
gence from other conventional human PSC cultures (Figures
S5A and S5B).
Reset cells display expression patterns characteristic of
ground-state ESC, in contrast to NHSM cultures where, remark-
ably, the expression of key pluripotency factors is often downre-
gulated or abolished (Figure 5C). The inverse trend was evident
when examining a range of lineage-specific genes, which are
heavily downregulated in ESC and reset cells but display
spurious expression in NHSM and 3iL cultures (Figure 5D). A
number of chromatin modifiers also exhibited expression more
comparable to mouse ESC for reset cells than for alternative
cultures, with NHSMcells lacking expression of important epige-
netic regulators such as MLL3, NCOA3, and TETs (Figure S5C).
In line with the observed DNA hypomethylation in reset cells,
transcripts for DNMT3B were greatly reduced and for DNMT3L
increased (Neri et al., 2013).
To evaluate whether the ground-state pluripotency factors
defined in mouse and upregulated in human reset cells are
indeed features of human naive pluripotency, we examined
two key factors, TFCP2L1 and KLF4, in human embryos. Super-
numerary embryos were thawed and cultured to the expanded
blastocyst stage for immunostaining (Roode et al., 2012). We de-
tected KLF4 exclusively in the ICM (Figure 5E). TFCP2L1 signal
was unambiguous in a subset of the KLF4-positive cells within
the ICM. Thus, the ICM in the mature human blastocyst contains
cells double positive for KLF4 and TFCP2L1 protein. Neither
factor is upregulated in previously described human PSC (Fig-
ure 5C), but they are coexpressed along with NANOG in reset
cells (Figure 5F), as in mouse ESC.
Executive Operation of Ground-State Transcription
Factor Circuitry
To determine whether the ground-state transcription factor
circuitry is functional in reset cells, we tested dependency on
specific factors using RNAi. siRNA against nonessential naive
pluripotency markers REX1 (ZFP42) and STELLA (DPPA3) did
not impair colony formation by either reset or conventional
PSC (Figure 6A). In contrast, knockdown of KLF4 or TFCP2L1
markedly reduced colony formation by reset cells but had little
effect on conventional cultures. We then used shRNA for consti-
tutive knockdown (Figure S6A). When NANOG and KLF2 trans-
genes weremaintained with DOX, TFCP2L1 orKLF4 knockdown
was tolerated but cells showed reduced colony formation (Fig-
ures 6B and 6C). After DOX withdrawal, colony formation was
largely abolished by knockdown in t2iL+Go¨ but was unaffectedFigure 4. Epigenome Analysis
(A) Immunostaining for 5mC, 5hmC, and NANOG. Conventional PSC exhibit pro
(white arrow) in contrast to feeder cells (unfilled arrow).
(B) Quantification by mass spectrometry of global 5mC and 5hmC levels.
(C) Quantitative summaries of whole-genome BS-seq data from three biological
(D) Heatmaps ofmethylation levels in up to 10,000 random samplings of previously
and intergenic CGI; exons; introns; LINEs and SINEs.
(E) Scatter plots of CGI methylation percentages on the X chromosome and auto
(F) Immunostaining for H3K27me3, counterstained with DAPI. Representative fie
(G) Immunostaining for H3K9me3. Intensity and distribution analysis by Image J.
Scale bars: (F and G) 20 mM. Error bars indicate SD. See also Figure S3.
Cin FGF/KSR/ROCKi, where cells adopted flattened conventional
PSC morphology (Figures 6C and S6B). KLF4 shRNA targets
the 30UTR, and expression of human KLF4 fully restored colony
formation (Figure 6D). TFCP2L1 shRNA targets the coding
sequence, but the knockdown phenotype was partially rescued
by mouse Tfcp2l1 (Figure S6C).
Mouse ESC can withstand Tfcp2l1 depletion due to compen-
sation by Esrrb (Martello et al., 2013). Reset human cells may
be sensitized due to weak expression of ESRRB. We therefore
tested whether transgenic ESRRB can rescue colony forma-
tion upon TFCP2L1 knockdown. Indeed, ESRRB expression
rendered reset cells resistant to TFCP2L1 shRNA such that
they formed multiple colonies in t2iL+Go¨ that had refractile
domed morphology and could be expanded after passaging
(Figure 6E).
These findings indicate that the self-renewal of reset human
cells, but not conventional PSC, is strongly reliant on TFCP2L1
and KLF4 and furthermore point to conserved functionality of
ground-state transcription factors between mouse and human,
even though individual factor expression may be altered.
As a potential functional test of naive epiblast identity, we
introduced reset cells into mouse preimplantation embryos
and monitored development in vitro. We first used fibroblast-
derived induced PSC stably transfected with CAG-Cherry before
and after resetting. After morula aggregation using conventional
iPSC, we did not detect any Cherry-positive cells in 37 blasto-
cysts. In contrast, reset cells contributed to the ICM in 6 of 42
blastocysts and in some cases appeared well integrated in the
epiblast compartment (Figure 6F). We repeated this test on reset
cells harboring a GFP reporter and found GFP-positive cells
within the ICM/epiblast in 8 of 49 blastocysts. We also assessed
whether reset cells could be incorporated into the ICM by blas-
tocyst injection. Injected embryoswere cultured for 72 hr to allow
hatching and primary ICM outgrowth. Of 32 injected embryos,
9 showed GFP-positive cells within the mature ICM/epiblast
(Figure 6G). In contrast, none of 17 blastocysts injectedwith con-
ventional Shef6 PSC showed colonization.
These data suggest that human reset cells are sufficiently
similar to mouse naive cells to allow incorporation into the ICM
and preimplantation epiblast.
Transient Transgenesis and Stable Resetting
We investigated the time span for resetting and found that
8 days of induction was sufficient (Figure 7A). Equivalent
expression should be achievable by transient transgenesis. To
identify and select reset cells, we exploited the EOS constructnounced 5mC staining (white arrow). Reset cells display reduced 5mC signal
replicates.
classified genomic regions: CpG island (CGI) or non-CGI promoters; intragenic
somes.
lds of reset cells and after passaging in FGF/KSR.
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Figure 5. Comparative Expression Analysis
(A) PCA of RNA-seq andmicroarray data from this study with RNA-seq data from Chan et al. (2013), microarray data fromGafni et al. (2013), and single-cell RNA-
seq data from Yan et al. (2013). Samples generated in this study were additionally hybridized to the identical array platform used by Gafni et al. (2013) to facilitate
direct comparison. Data were normalized to conventional PSC in each study. Similar clustering is apparent using RNA-seq data alone (Figure S4B), discounting
the influence of platform differences.
(legend continued on next page)
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(Hotta et al., 2009) incorporating the mouse Oct4 distal
enhancer active in naive, but not primed, pluripotent cells.
We transfected H9 and Shef6 cells bearing an integrated PB-
EOS-GFP/puroR construct with constitutive expression plas-
mids for NANOG and KLF2 (Figure 7B). In pilot studies, we
observed that CH appeared inhibitory to the resetting process
and that addition of the FGF receptor inhibitor PD17 might favor
resetting. Accordingly, 2 days after transfection, medium was
switched from FGF/KSR to N2B27 supplemented with PD17,
PD03, and LIF. At day 4, cells were retransfected, and on day
8, medium was changed to t2iL+Go¨. From day 12, several
GFP-positive clusters of cells became visible and puromycin
selection commenced. Cultures were heterogeneous and
were passaged four times before discrete colonies were picked
(Figure 7C). Seven of nine cultures showed no detectable trans-
gene at single-copy resolution (Figure 7D). They were indistin-
guishable in morphology from cultures in which transgenes
were detected or from reset cells generated with inducible
transgenes. qRT-PCR and immunostaining confirmed sustained
expression of ground-state pluripotency factors (Figures 7E and
7F). Passaging time was comparable to reset cells generated
via inducible transgene expression, as was colony formation
efficiency of 5%–10% without ROCKi. Colony formation in the
presence of A83-01 (Figure 7G) demonstrated independence
from activin/nodal, unlike other human PSC. Furthermore,
knockdown of TFCP2L1 or KLF4 significantly impaired colony
formation (Figure 7H), indicating dependency on ground-state
transcription factors.
We conclude that the reset state can be generated without
permanent genetic modification.
DISCUSSION
The postulate that a self-renewing ground state similar to rodent
ESC may pertain to primates is contentious. Our findings indi-
cate that anticipated ground-state properties may be instated
in human cells following short-term expression of NANOG and
KLF2 transgenes. The resulting cells can be perpetuated in
defined medium lacking serum products or growth factors.
Feeders support attachment and growth of reset cells but are
dispensable. Reset human stem cells show global changes in
DNA methylation and transcription suggestive of a more primi-
tive state. They also display altered metabolism with increased
mitochondrial respiration. This constellation of features distin-
guishes reset cells from previous embryo-derived or induced
human PSC and aligns them closer to ground-state mouse
ESC. Most significantly, the unique transcription factor circuit
essential for mouse ESC identity, self-renewal and pluripotency,
is functionally operative in sustaining the reset human pluripotent
state.(B) RNA-seq meta-analysis reveals two major groups, with reset cells featuring
expression level in each sample scaled by the mean expression of each gene ac
(C) Reset cells display transcription factor hallmarks of ground-state ESC. Data
(D) Reset cells feature downregulation of lineage markers.
(E) Immunostaining of KLF4 and TFCP2L1 in the human ICM.
(F) Coexpression of KLF4, TFCP2L1, and NANOG in reset cells.
Scale bar: (E and F) 50 mM. See also Figures S4 and S5 and Tables S2, S3 and S
CPrevious claims of putative naive human PSC (Chan et al.,
2013; Gafni et al., 2013;Ware et al., 2014) have employed culture
media with an incoherent array of growth factors and inhibitors.
One possibility is that such compound conditions may select for
propagation of heterogeneous cultures comprising cells co-hab-
iting in different phases of pluripotency, as described for mouse
EpiSCs (Bernemann et al., 2011; Tsakiridis et al., 2014). Lack
of enrichment for naive pluripotency factors and expression of
mixed lineage markers (Figures 5C and 5D) are consistent with
such an explanation.
While this study was in revision, Theunissen et al. (2014) re-
ported that PSC cultured in a cocktail of six kinase inhibitors
plus LIF and activin (6i/L/A) on feeders expressed naive features.
We incorporated their data into the transcriptomemeta-analysis.
Use of an alternative microarray platform precludes quantitative
comparison of individual genes, but PCA reveals that 6i/L/A cells
are globally well separated from previously described PSC while
forming a distinct cluster from reset cells (Figure S7A). Upregula-
tion of naive markers and downregulation of lineage markers
appears comparable to reset cells, but some differences are
apparent in expression of epigenetic modifiers (Figure S7B).
Notably, methylation regulators DNMT3a and TET1 change in
opposite directions. Methylome status is not described by The-
unissen et al. (2014), but they report X chromosome inactivation,
in contrast to reset cells. Both X chromosomes are active in
the human ICM (Okamoto et al., 2011), and the timing of inacti-
vation is uncertain. Epiblast development is more protracted in
primates than in rodents, raising the possibility that differences
between reset and 6i/L/A cells may reflect successive phases
of pluripotency.
Independence from Erk signaling is a hallmark of rodent naive
cells that is conserved in human preimplantation epiblast (Roode
et al., 2012). We used 1 mM PD03 to ensure full inhibition of the
Erk pathway. In contrast, GSK3 inhibition is only partial and dif-
fers between mouse and human cells. This may reflect the bal-
ance between relief of TCF3 repressor function and activation
of canonical TCF/LEF factors (Chen et al., 2013). Moreover, in
mouse ESC, GSK3 inhibition acts mainly through derepression
of Esrrb (Martello et al., 2013), but ESRRB is weakly expressed
in reset human PSC. Poor conservation of a genomic interval
in which NANOG, OCT4, SOX2, and TCF3 bind mouse Esrrb
may underlie this lack of expression (Figure S8). ESRRB is a
potent self-renewal factor in ESC (Festuccia et al., 2012; Martello
et al., 2012), and its noninductionmay explain the insufficiency of
2iL for human cells. Go¨6983 is a broad specificity PKC inhibitor
that facilitates mouse ESC self-renewal (Dutta et al., 2011). Mu-
tation of atypical PKC iota largely recapitulates this effect in ESC
(Leeb et al., 2014), whereas knockdown of aPKC iota in reset
cells enhances propagation in t2iL without Go¨ (Figure S9). The
mechanism downstream of aPKC inhibition remains to beexpression patterns most similar to ESC. Values displayed correspond to the
ross samples.
normalized to expression from conventional human PSC as above.
4.
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elucidated, but we speculate that differentiation may be inhibited
by interfering with acquisition of epithelial polarity, an essential
feature of postimplantation epiblast. On transfer to FGF/KSR,
reset cells flatten and progressively adopt typical human PSC
appearance and growth factor dependence. This process re-
sembles mouse ESC to EpiSC differentiation and may mimic
pre- to postimplantation epiblast progression.
Rodent ground-state ESCare distinguished by and dependent
on a suite of transcription factors additional to Oct4, Sox2, and
NANOG (Nichols and Smith, 2012). Each of these is individually
dispensable due to overlapping functions in a flexible circuitry
(Dunn et al., 2014). They are absent or very lowly expressed in
EpiSC and conventional human PSC. In reset cells, all are pre-
sent apart from ESRRB. Absence of ESRRB is anticipated to
render the ground-state circuitry more fragile (Figure 7I). Severe
compromise to self-renewal upon KLF4 or TFCP2L1 knockdown
is in line with this prediction and provides evidence that reset hu-
man PSC are functionally governed by the rewired ground-state
transcription factor circuitry. Rescue of TFCP2L1 knockdown
cells by ESRRB points to further functional conservation with
the mouse ESC control system.
Our findings suggest that authentic ground-state pluripotent
stem cells may be attainable in human, lending support to the
notion of a generic naive state of pluripotency inmammals. In hu-
man, the naive-state transcription factor circuitry appears in
large part to be conserved but requires greater reinforcement
to be stably propagated. Disposition to collapse reflects the tran-
sient nature of naive pluripotency in the embryo (Nichols and
Smith, 2009). The imperative for developmental progression
may be intrinsically stronger in primates that, unlike rodents,
have not evolved the facility for embryonic diapause (Nichols
and Smith, 2012). Nonetheless, increased number and size of
colonies under conditions of transgene induction suggest that
there may be scope to refine and further improve culture condi-
tions for human ground-state PSC.
Further evaluation of the ground-state hypothesis remains
necessary. Reset cells might be considered a synthetic product
of genetic intervention. Seamless derivation from human
epiblast is therefore a key future landmark. Formation of primary
chimeras, a powerful test of naive status and developmental po-
tency in rodents, cannot be undertaken in human. However, the
finding that reset cells can consistently be incorporated into the
mouse ICM/epiblast distinguishes them from conventional hu-
man PSC ormouse EpiSC and is consistent with preimplantation
identity. Interestingly, upon further culture to mimic early postim-
plantation stages (Bedzhov and Zernicka-Goetz, 2014), contri-
bution of human cells to the epiblast was no longer detected.Figure 6. Functional Interrogation of the Reset State
(A) Colony formation after siRNA knockdown in 4,000 cells in FGF/KSR or 2,000 c
relatively consistent. Histogram shows mean colony counts from duplicate assa
(B) Colony formation after shTFCP2L1 knockdown (KD) in indicated conditions.
(C) Quantification of colony formation by shTFCP2L1 or shKLF4 knockdown cell
(D) Rescue of KLF4 knockdown with KLF4 transgene.
(E) Colony formation by shTFCP2L1 knockdown cells transfected with ESRRB.
(F) Morula aggregation. Six of 42 embryos aggregated with reset cells contained
(G) Blastocyst injection. After 72 hr, 9 of 32 embryos injected with reset cells sho
Error bars indicate SD. See also Figure S6.
CThese data are preliminary but may suggest that human cells
are unable to adjust to the much faster rate and/or distinct
morphogenetic organization of mouse postimplantation epiblast
development. Later, contribution to same-species chimeras
could be explored in nonhuman primates. Perhaps the
most important question, however, at least from a translational
perspective, is whether rewiring transcriptional circuitry also
removes epigenetic specifications. Human genetic variation
notwithstanding, epigenome status may influence consistency
of both undifferentiated phenotype and differentiation behavior.
Low H3K9me3 and genome-wide DNA hypomethylation point to
epigenome erasure in reset cells, as in early embryos. It will be of
great interest to determine the precise functional impact of such
epigenetic cleansing.
EXPERIMENTAL PROCEDURES
Other procedures and reagent details are provided in the Extended Experi-
mental Procedures.
Cell Culture
Human-embryo-derived H1, H9, and Shef6 and iPS cells were maintained in
conventional PSC culture conditions with FGF/KSR on feeders.
piggyBac (PB) vectors (2 mg) carrying doxycycline-inducible KLF2 or
NANOG coupled to Venus were cotransfected with an rtTA expression
construct (2 mg) and pBase helper plasmid (4 mg) using the Neon Transfec-
tion System (Program 14; Invitrogen). Two days later, G418 was applied
(100 mg/ml). After selection for 2 weeks, Venus-positive cells with leaky
transgene expression were removed by flow cytometry. Transfectants were
dissociated with trypsin and replated in the presence of Rho-associated
kinase inhibitor (ROCKi) (Y-27632, Calbiochem) prior to addition of DOX
(1 mM) on day 1. On day 2, medium was changed to N2B27 medium (Ndiff227,
StemCells Inc.) with 1 mM PD0325901 (PD03), human LIF (prepared in house),
CHIR99021 (3 mM; 2iL; 1 mM, t2iL), and DOX. Mediumwas changed daily. Cells
were split every 5–7 days after dissociation with Accutase (Life Technologies).
After 2 weeks, DOX was withdrawn and PKC inhibitor Go¨6983 added (5 mM,
Sigma-Aldrich). Cells transferred to t2iL+Go¨ expand slowly for the initial couple
of passages after withdrawal of DOX. Subsequently, cultures in t2iL+Go¨ were
passaged every 5–7 days using Accutase. Cells were maintained on MEF
feeders throughout.
For transient expression and resetting, we established H9 and Shef6 cells
with a PB-EOS-GFP/puroR reporter (Hotta et al., 2009). This reporter is pro-
gressively silenced in conventional PSC but is re-expressed upon resetting.
EOS cells were transfected with 3 mg of circularNANOG and KLF2 constitutive
expression plasmids. Two days later, medium was switched to N2B27 with
PD173074 (PD17, 0.5 mM), PD03 (0.5 mM), and hLIF. At day 4, cells were
retransfected, and on day 8, medium was changed to t2iL+Go¨. Puromycin
selection (0.5 mg/ml) was applied from day 12 for two passages to enrich for
EOS-expressing cells. Colonies were picked on passage 4 or 5. Presence or
absence of transgene vectors was assayed by genomic PCR for the CAG
promoter and TaqMan Copy Number Assays against the blasticidin resistance
gene with RNase P and TERT reference assays.ells in t2iL+Go¨. Colony size is variable for conventional PSC, but numbers are
ys.
s.
Cherry-positive cells, as shown. Scale bar, 20 mM.
wed GFP-positive cells in the ICM/epiblast, as shown. Scale bar, 100 mM.
ell 158, 1254–1269, September 11, 2014 ª2014 The Authors 1265
t2iL+Dox 15 days t2iL+Dox 8 days        t2iL+Gö 7 days
H9 H1 Shef6-EOS H9 H1 Shef6-EOS
AP
KLF4
DAPI
Venus
 or 
GFP
A
B C
0
0.05
0.1
0.15
0.2
0.25
0.3
FGF/KSR 14 18 Reset
control
NANOG
0
0.005
0.01
0.015
0.02
FGF/KSR 14 18 Reset
control
TBX3
0
0.2
0.4
0.6
0.8
1
1.2
FGF/KSR 14 18 Reset
control
OCT3/4
0
0.01
0.02
0.03
0.04
FGF/KSR 14 18 Reset
control
TFCP2L1
0
0.02
0.04
0.06
0.08
0.1
FGF/KSR 14 18 Reset
control
KLF4
D
E
0
1
2
3
4
0
1
2
3
4
11 14 15 16 18 19 20 25 26
control
+-
co
py
 n
um
be
r
Normalised by TERT
control
+-
Normalised by RNase P
SiRNA_1
SiRNA_2
0
20
40
60
80
100
120
AP colony number
0
50
100
150
200
250
300
350
t2iL+Gö
PD17A83
t2iL
F
H
AP colony number
Ground State Transcription Factor
Circuitry
I
H9 passage13
NANOG
KLF4
TFCP2L1
STELLA
TFE3
G
DAPI
NANOG and KLF2
FGF/KSR
2 days 2days
H9 or Shef6
with EOS-GFP
+PD03
+PD17
+LIF
NANOG and KLF2
+PD03
+PD17
+LIF
6days t2iL+Gö
R
el
at
iv
e 
ex
pr
es
si
on
 n
or
m
al
is
ed
 to
 G
A
P
D
H
cell line
cell line
TFCP2L1 KD
KLF4 KD
TFCP2L1 KD
+ ESRRβ
collapse
collapse self-renewal
Conventional PSC
+NANOG
+KLF2
FGF/KSR
Reset cells
t2iL+Gö
self-renewal
cell line
cell line
cell line
cell line
11 14 15 16 18 19 20 25 26
cell line
Shef6 passage6
(legend on next page)
1266 Cell 158, 1254–1269, September 11, 2014 ª2014 The Authors
For colony-forming assays, we plated 1,000 cells per well in 24-well plates,
2,000 cells for 12-well plates, and 5,000 cells for 6-well plates. ROCKi was
added for conventional but not reset cells.
For feeder-free culture, plates were coated overnight at 4C with either
diluted BD Matrigel hES-qualified Matrix (1:30) or Laminin 511-E8 (iMatrix-
511; Nippi) at 0.5 mg/cm2. Cells were dissociated in the presence of ROCKi
and plated in t2iL with Go¨ reduced to 2 mM.
Human Embryos
Human embryo research was licensed by the UK Human Fertilization and
Embryology Authority. Supernumerary embryos donated from in vitro fertiliza-
tion programs with informed consent were thawed and cultured to day 7 post-
fertilization. Blastocysts were fixed in 4% PFA, immunostained, and imaged
as described (Roode et al., 2012).
Transcriptome Meta-Analysis
Sequencing reads were aligned to the human genome build hg19/GRCh37
with the STAR aligner (Dobin et al., 2013) using the two-pass method for splice
junction detection (Engstro¨m et al., 2013). Transcript quantification was per-
formed with htseq-count, part of the HTSeq package (Anders et al., 2014),
using GENCODE v15 (Harrow et al., 2012) human gene annotation (Ensembl
release 70) (Flicek et al., 2014). Sequencing reads from published RNA-seq
experiments were obtained from the European Nucleotide Archive (ENA). To
ensure maximal compatibility between data sets, raw counts were generated
in the manner described above and all RNA-seq samples were processed
together. Mouse and human samples were related via one-to-one orthologous
genes annotated in Ensembl v70. Libraries were corrected for total read count
using the size factors computed by the Bioconductor packageDESeq (Anders
and Huber, 2010) and were normalized for gene length to yield FPKM values.
To generate expression heatmaps, FPKM values were scaled relative to the
mean expression of each gene across all samples. Heatmaps include genes
for which a difference in expression was observed (i.e., scaled expression >
1 or <1 in at least one sample). Principal components were computed by sin-
gular value decomposition with the princomp function in the R stats package,
using expression levels normalized relative to the human embryo-derived PSC
samples in each study.
Affymetrix Human Gene Array 1.0 ST arrays were processed with the oligo
Bioconductor package (Carvalho and Irizarry, 2010) to summarize probe-set
transcript clusters. Microarray data from this study were normalized together
with those from Gafni et al. (2013) using the robust multi-array average (RMA)
method (Irizarry et al., 2003) applied through the oligo package. Principal
components were calculated from the centered and scaled expression
covariance matrix by singular value decomposition, computed by the
prcomp function in the R stats package. Transcript clusters were associated
with targeted genes based on GENCODE v15 human genome annotation
(Ensembl release 70). Where multiple probe sets for a given gene were pre-
sent on the array, these were summarized using the maximal expression
value. Expression data for heatmaps were scaled relative to the mean
expression of each gene across all samples. Affymetrix PrimeView arrays
from Theunissen et al. (2014) were normalized with the RMA algorithm imple-Figure 7. Resetting by Transient Transgenesis
(A) Time span for resetting with inducible NANOG and KLF2. At day 8, cultures we
Few colonies are obtained with DOX exposure <6 days. Reporter expression in Sh
constant for all images, yielding lower EOS-GFP signal relative to hCMV-Venus.
(B) Scheme for generation of reset cells by transient transfection.
(C) Phase contrast and fluorescence images of reset cells generated by transien
(D) Detection of transgene-free cultures by TaqMan copy number assay. Cells w
(E) qRT-PCR assay for transcription factor expression in expanded transgene-fre
(F) Immunofluorescence staining of expanded transgene-free reset cells.
(G) Colony-forming assays on transgene-free reset cells seeded in the indicated
(H) Colony formation after siRNA knockdown in transgene-free reset cells. Histo
(I) ESC express general pluripotency factors Oct4 and Sox2 plus an interconnec
expression of these factors in human PSC apart from ESRRB. Self-renewal is les
causes collapse.
Error bars indicate SD.
Cmented in the affy Bioconductor package using a modified CDF environment
to annotate ERCC control probes.
RNA-seq data were cross-referenced with the microarray data, restricting
the analysis to the genes interrogated by each array design. To account for
technical differences between experiments and platforms, expression levels
were computed relative to the human embryo-derived PSC samples from
each study. These values were used as the basis for global PCA and compar-
ative analysis of marker genes.
Embryo Chimeras
Cells were stably transfected with PB-Cherry or PB-GFP reporters. Five to
ten cells were aggregated with eight-cell stage mouse embryos and imaging
performed 48 hr later at the expanded blastocyst stage. Alternatively, 8–12
cells were injected per blastocyst (E3.5) with imaging of hatched outgrowths
72 hr later. In some cases, outgrowths were cultured further to form egg cylin-
der-like rosettes (Bedzhov and Zernicka-Goetz, 2014).
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Supplemental Information
EXTENDED EXPERIMENTAL PROCEDURES
Cell Lines and Culture Details
Human embryo-derived cells used were H1, H9 (WiCell Research Institute) (Thomson et al., 1998) and Shef6 (Aflatoonian et al.,
2010). Human iPS cells were generated from adult keratinocytes (Invitrogen), fibroblasts (Invitrogen), or adipose-derived stem
cells (Invitrogen). Conventional PSC medium (FGF/KSR) comprised DMEM/F-12 (Sigma-Aldrich) with 10 ng/ml bFGF (prepared
in-house) and 20% KSR (Invitrogen) supplemented with 100 mM 2-mercaptoethanol (2ME) (Sigma-Aldrich M7522), MEM non-
essential amino acids (NEAA) (Invitrogen 11140050), 2 mM L-glutamine (Invitrogen, cat. 25030024). Cultures were passaged every
five to seven days as small clumps by dissociation with 0.025% Trypsin, 1 mg/ml Collagenase IV (Invitrogen 17104-019), KSR
(final 20%), 1mM CaCl2. Throughout this study cells were maintained on irradiated mouse embryonic fibroblasts (MEF) in 5%
oxygen.
Colony assays were scored by fixing and staining for alkaline phosphatase, typically 7 days after plating. For proliferation assays
triplicate wells were seeded with 1x105 cells. Cultures were dissociated, counted and passaged every 6 days, reseeding at the start-
ing density.
Mouse ES cells were cultured on feeders in PD03 + LIF, t2iL or t2iL+Go¨ to produce RNA for comparative transcriptome
analyses.
In Vitro Differentiation
For embryoid body formation, 10,000 reset cells dissociated with Accutase were plated per well of a PrimeSurface 96V cell plate
(Sumitomo Bakelite MS-9096V) in two differentiation media: GMEM (Sigma G5154) with L-glutamine, pyruvate, 2ME and NEAA
plus 10% serum; or N2B27 with 10% KSR. Medium was changed every second day. RNA was prepared from cells harvested at
days 0, 5, and 10. For endoderm differentiation, reset cells were seeded on Matrigel (growth factor reduced, BD, 356230) coated
plates in mTeSR medium for one week and then transferred into RPMI with 100 ng/ml activin A (prepared in-house) and 25 ng/ml
mouse Wnt3A (R&D Systems) (Kroon et al., 2008). The following day medium was changed to RPMI with 100ng activin A and
0.2% serum. Flow cytometry for CXCR4 and E-cadherin was performed at day 3 and immunofluorescence for SOX17 and FOXA2
was performed at day 4. For cardiomyocyte differentiation, reset cells were passaged in FGF/KSR medium on MEF feeder cells
then 10,000 cells were plated per V-bottom well in MEF-conditioned FGF/KSR medium containing 10 mM ROCKi. At day 3 medium
was changed to DMEM/F-12 with 20% FBS, L-glutamine, MEM amino acids (Life Technologies 11130), 2-mercaptoethanol, and
50 mg/ml ascorbic acid (Moretti et al., 2010). At day 7, aggregates were seeded on gelatin-coated wells. Differentiation medium
was changed every two days. Beating foci appeared from 21 days. For neural induction, reset cells were first cultured in FGF/
KSR for a minimum of 6 days. Dissociated cells were then seeded on Matrigel (growth factor reduced, BD 356230) coated plates
in mTeSR for two days before medium was changed to Ndiff227 (StemCells Inc.) with 10 ng/ml FGF, 20 mM SB431542
and 260 ng/ml Noggin (R&D) (Chambers et al., 2009). At day 5, medium was changed to Ndiff227 with 10 ng/ml FGF, 20 mM
SB431542. At day 10, cells were fixed and stained for TUJ1 and NEUN.
Teratoma Formation
Studies were carried out in a designated facility under licenses granted by the UKHomeOffice. Approximately 105 cells were injected
under renal capsules of NOD/SCID mice. After 12 weeks teratomas were excised, fixed with 4% PFA, sectioned and stained with
hematoxylin and eosin.
Karyotype Analysis
KaryoMAX (Invitrogen, final concentration 0.06 mg/ml) was added to culture medium and cells incubated for 6 hr at 37C. Cells in
suspension were collected and washed in PBS, then incubated in 5ml of a pre-warmed (37C), 0.075M potassium chloride for
10 min (37C). After centrifugation, 4ml fixative (3:1 methanol:acetic acid) was added. This fixation step was repeated twice. Fixed
samples were analyzed as G-banded karyotypes at the Medical Genetics Laboratories, Cambridge University Hospitals NHS Foun-
dation Trust.
Genome Integrity
The CytoScan HD Array platform (Affymetrix) was used to screen for chromosomal abnormalities. Genomic DNA was isolated by
QIAamp mini kit (QIAGEN 51304) and analysis performed at Center for Genomic Medicine, Copenhagen University Hospital.
Reverse Transcription Quantitative Real-Time PCR
Total RNA was isolated using the RNeasy kit (QIAGEN) and complementary DNA (cDNA) made from 1000ng of RNA using
SuperScript III (Invitrogen) and oligo-dT primers. For real-time PCR, we used TaqMan Fast Universal Master Mix and TaqMan probes
(Applied Biosystems) or the Universal Probe Library (UPL, Roche) system. Two or three technical replicates and at least two inde-
pendent cultures were assayed for all quantitative PCR reactions. An endogenous control (Human GAPD, Applied Biosystems
4352934E) was used to normalize expression. Primers and UPL probe numbers are listed below.Cell 158, 1254–1269, September 11, 2014 ª2014 The Authors S1
Taqman
Gene Taqman probe
NANOG Hs02387400_g1
KLF2 Hs00360439_g1
OCT3/4 Hs03005111_g1
TBX3 Hs00195612_m1
REX1 Hs00399279_m1
TFCP2L1 Hs00232708_m1
KLF4 Hs00358836_m1
GBX2 Hs00230965_m1
SALL4 Hs00360675_m1
ESRRB Hs01584024_m1
SOX17 Hs00751752_s1
CXCR4 Hs00607978_s1
FOXA2 Hs00232764_m1
T Hs00610080_m1
PDGFRA Hs00998018_m1
PDGFRB Hs01019589_m1
SOX1 Hs01057642_s1
PAX6 Hs01088112_m1
MAP2 Hs00159041_m1
NKX2-2 Hs00159616_m1
TNNT2 Hs00165960_m1
MYOCD Hs00538071_m1
PRKCZ Hs00177051_m1
PRKCI Hs00995854_g1
hCMV1NANOG Custom TaqMan Assays*
hCMV1KLF2 Custom TaqMan Assays*
KLF2 endo Custom TaqMan Assays*
NANOG endo Custom TaqMan Assays*
Endo probes detect 30-UTR of endogenous NANOG and KLF2 transcripts. Transgene specific probes cover the junction between vector and cDNA.
UPL
Gene Primer Sequence UPL probe
STELLA U_STELLA R tggtagcaatttgaggctctg #80
U_STELLA L atcggcgtcttgacacaac
ISL1 U_ISL1 L aaggacaagaagcgaagcat #66
U_ILS_1 R ttcctgtcatcccctggata
Genomic PCR
DNA was isolated by QIAamp mini kit (QIAGEN 51304). The Copy Number Assay was performed following manufacture’s protocol
(Life Technologies). 20ng of DNA were used per assay with four technical replicates.
Genomic PCR Primers
CAG R ATTACCATGGGTCGAGGTGA
CAG L AGAAAAGAAACGAGCCGTCA
Copy Number Assay (Taqman)
BsdR Mr00733720_cn
Reference Assay, hRNase P 4403326
Reference Assay, hTERT 4403316
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Immunostaining
Cells were fixed in 4% paraformaldehyde for 10 min, then blocked with 2% donkey serum/PBS + 0.1% BSA + 0.1% Triton (PBSBT)
for 2 hr. Primary antibodies were diluted in PBSBT and incubated at 4C overnight. Secondary antibodies were diluted 1:1000 and
incubated at room temperature for 1 hr. Nuclei were counterstained with DAPI. Staining of methylated DNA was performed as pre-
viously described (Ficz et al., 2013). Cells were fixed by 4% PFA for 10 min. After permeabilisation by PBS+0.5% Triton for 1 hr, fixed
cells were incubated in 2N HCl for 30 min, washed and then and then blocked in PBSBT for 2 hr. Cells were incubated in 1:250 5mC
(Eurogentec BI-MECY) and 1:500 5hmC (Active Motif 39769)/PBSBT. Nuclei were stained with DAPI. Antibody details are provided
below.
Antibody Company Cat NO Dilution
NANOG Abcam ab21624 1:200
NANOG eBioscience 14-5769-82 1:200
KLF4 Santa Cruz sc-20691 1:400
TFCP2L1 R and D AF5726 1:500
TFE3 Sigma HPA023881-100UL 1:500
STELLA Millipore MAB4388 1:200
ECAD Beckman Coulter IM1763 1:100
CXCR4 BD Pharmingen 555974 1:100
SOX17 R and D AF1924 1:200
FOXA2 Abnova H00003170 1:200
TuJ1 R and D MAB1195 1:200
NEUN Millipore MAB377 1:100
5-hmC Active Motif 39769 1:500
5-mC Eurogentec BI-MECY-0100 1:250
H3K9me3 active motif 39765 1:500
ERK1/2 Cell Signaling #9107 1:1000
pERK1/2 Cell Signaling #4376 1:1000
alpha Tublin Abcam ab7291 1:5000
Flow Cytometry
Following dissociation with accutase or trypsin/EDTA, cells were blocked in donkey serum on ice for 20min. Cells were stained on ice
with E-cadherin antibody and CXCR4 antibody conjugated with PE in HBSS (Invitrogen) with 1%BSA for 20 min. After washing, APC
Rat Anti-Mouse IgG1 secondary antibody (BD Pharmingen 550874) was applied. Flow cytometry analyses were performed using a
Dako Cytomation CyAn ADP high-performance cytometer with Summit software.
Cell Metabolism Assays
Oxygen consumption was measured using an XFe24 Analyzer (Seahorse Bioscience) according to the manufacturer’s protocol. In
brief, Seahorse plates were pre-treated by coating with laminin and 80,000 cells were seeded on each well the night before the
experiment. Culture media were exchanged for XF Base Medium (Seahorse Bioscience) supplemented with 2mM pyruvate and
20mM glucose with an adjusted pH of 7.4 and cells incubated at 37C in atmospheric CO2 for one hour. Oligomycin (2 mM),
FCCP (500 mM), antimycin (1 mM) and rotenone (1 mM) were injected during the assay (XF cell mito stress test kit, Seahorse Biosci-
ence). Mitochondria were stained with MitoTracker Green FM (final concentration 50nM, Life Technologies) or tetramethylrhod-
amine, ethyl ester (TMRE, final concentration 20nM, Life Technologies) in the relevant medium for 10 min and analyzed by confocal
microscopy.
Mass Spectrometry of Nucleosides
Genomic DNA was digested using DNA Degradase Plus (Zymo Research) according to the manufacturer’s instructions and
analyzed by liquid chromatography-tandem mass spectrometry on a Q-Exactive mass spectrometer (Thermo Scientific) fitted
with a nanoelectrospray ion source. Mass spectral data for C, 5mC and 5hmC were acquired in selected reaction monitoring
(SRM) mode, monitoring the transitions 228 / 112.0505 (C), 242 / 126.0662 (5mC) and 258 / 142.0611 (5hmC). Parent
ions were isolated using a 1 mass unit window, fragmented with a normalised collision energy of 10%, and MS/MS spectra re-
corded with a resolution >45,000 for the fragment ions. Peak areas for the fragment ions were obtained from extracted ion chro-
matograms of the relevant scans and quantified by external calibration relative to standards obtained by digestion of nucleotidetriphosphates.
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BS-Seq Library Preparation and Analysis
Genomic DNA was prepared using AllPrep DNA/RNA mini kit (QIAGEN), fragmented by sonication (Covaris) and ligated to meth-
ylated adapters (Illumina) with the NEBnext library preparation kit (New England BioLabs). DNA was subsequently bisulfite-
treated using the Sigma Imprint kit according to the manufacturer’s instructions (one step protocol). Final library amplification
(11 cycles) was performed with KAPA Uracil+ (Kapa Biosystems), after which the libraries were purified using 1x Ampure beads.
Sequencing reads were filtered to remove low-quality calls and adapters were removed using v0.2.2 of Trim Galore (www.
bioinformatics.babraham.ac.uk/projects/trim_galore) with default parameters. The remaining sequences were mapped to the hu-
man reference genome GRCh37 using Bismark v0.7.4 (Krueger and Andrews, 2011) with default parameters, and CpG methyl-
ation calls were extracted and analyzed using SeqMonk (www.bioinformatics.babraham.ac.uk/projects/seqmonk) and custom R
scripts. Global methylation comparison was calculated by averaging 1kb window methylation levels of CpGs covered by at least
30 reads. To determine CGI methylation percentages probes were generated over CGIs and filtered for a minimum of 1 methyl-
ation count/CG and at least 5 CGs/CGI. Methylation values represent the mean over each CGI, filtered by chromosome.
RNA Processing
Total RNA was extracted with the TRIzol/chloroform method (Invitrogen), followed by resuspension in RNAsecure (Ambion), incuba-
tion with TURBO DNase (Ambion) at 37C for 1 hr, further phenol/chloroform extraction and ethanol precipitation. RNA integrity was
assessed with the RNA 6000 Nano assay on the 2100 Bioanalyzer (Agilent).
Transcriptome Sequencing
Ribosomal RNA was depleted from 5 mg of total RNA using Ribo-Zero capture probes (Epicenter). RNA samples were sheared by
ultrasonication on a Covaris S2 for 90 s set at Duty Cycle 10, Cycles per Burst 200 and Intensity 5. Fragmented RNA was reverse-
transcribed with a combination of random hexamer and oligo-dT primers (New England Biolabs) by SuperScript III (Invitrogen) at
50C for 2 hr in the presence of 6 mg/ml actinomycin D (Sigma) to inhibit second-strand products. Second-strand cDNA was syn-
thesized by DNA Polymerase I in the presence of RNase H with dUTPs substituted for dTTPs at 16C for 2 hr. Sequential end
repair and 30-adenylation of cDNA products was carried out with T4 DNA polymerase and T4 polynucleotide kinase (20C),
and with exo- Klenow fragment (65C) in the presence of dATPs (New England BioLabs). These were ligated to barcoded adapters
(NEXTflex-96, Bioo Scientific) by T4 DNA ligase (New England BioLabs) at 20C for 30 min. Second-strand DNA was digested with
uracil DNA glycosylase (UDG) and Endonuclease VIII at 37C for 30 min. PCR amplification of first-strand library constructs was
carried out with KAPA HiFi DNA polymerase (Kapa Biosystems) for 13 cycles. Purification of reaction products at each step was
performed with Ampure XP paramagnetic beads (Beckman Coulter). Library size distribution and molarity was assessed by the
DNA 1000 assay on the 2100 Bioanalyzer (Agilent). Sequencing was performed on the Illumina HiSeq 2000 in 100bp paired-
end format.
Microarray Processing
Total RNA was extracted and DNase treated as above, then processed for microarray analysis using the Ambion WT Expression Kit.
Briefly, double-stranded cDNA was synthesized from 500 ng of RNA with random hexamers tagged with a T7 primer. Products were
subjected to in vitro transcription by T7 RNA polymerase to generate antisense cRNA. Samples were reverse-transcribed by
SuperScript III (Invitrogen) in the presence of dUTPs to yield single-stranded DNA. The template cRNA was then degraded by RNase
H and cDNAproducts were fragmented by uracil DNA glycosylase (UDG) and apurinic/apyrimidinic endonuclease 1 (APE 1) (Ambion).
Fragmented cDNA was then biotin-labeled by terminal deoxynucleotidyl transferase (TdT). Affymetrix Human Gene Array 1.0 ST
arrays were hybridized for 16 hr at 45C, washed, stained with streptavidin-phycoerythrin (SAPE) conjugate on a FS450 automated
fluidics station (Affymetrix), and imaged on a GCS3000 7G scanner (Affymetrix).
RNAi
siRNAs (QIAGEN, below) were transfected at a final concentration of 40nMusingDharmafect 1 (Dharmacon T-2001-01), following the
manufacturer’s protocol. For a 24-well plate (2cm2), we used 1 ml of transfection reagent in 50 ml of OptiMEM (Invitrogen), 1 ml of 20 mM
siRNA solution in 50 ml of OptiMEM, and 4000 conventional PSC in 0.4ml of FGF/KSRmedium or 2000 reset cells in 0.4ml of t2iL+ Go¨.
Medium was changed after overnight incubation.
si RNA List (QIAGEN)
Gene No siRNA Cat No
GFP GFP-22 siRNA 1022064
TFCP2L1 1 Hs_TFCP2L1_5 SI04206111
2 Hs_TFCP2L1_3 SI00743253
3 Hs_TFCP2L1_7 SI04312217
4 Hs_TFCP2L1_6 SI04230625
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si RNA List (QIAGEN)
Gene No siRNA Cat No
REX1 1 Hs_ZFP42_7 SI04280241
2 Hs_ZFP42_6 SI04221385
3 Hs_ZFP42_9 SI04306974
4 Hs_ZFP42_8 SI04304440
STELLA 1 Hs_DPPA3_1 SI00373233
2 Hs_DPPA3_3 SI00373247
3 Hs_DPPA3_8 SI04177642
4 Hs_DPPA3_7 SI03204705
KLF4 1 Hs_KLF4_5 SI03176733
2 Hs_KLF4_6 SI03649191
3 Hs_KLF4_4 SI00463253
4 Hs_KLF4_7 SI04144049
No 1 and 2 of were used for single siRNA knock down based on measurement of knock down efficiency by qRT-PCR.
shRNAs (Thermo Scientific, below) were introduced using the Neon Transfection System (Invitrogen), program 14 for conventional
PSC andNeon program 20 for reset cells with 2 mg of shRNA vector. Two days after electroporation, cells were selected in puromycin.
For rescue experiments, shRNA knockdown cells were transfected using Neon program 14 with 1.5 mg of piggyBac vector carrying a
Tfcp2l1, KLF4 or ESRRB expression cassette plus 1.5 mg of pBase and selected in hygromycin.
TRC human shRNA Thermo scientific
Gene clone ID
TFCP2L1 TRCN0000017760 TFCP2L1_3
TFCP2L1 TRCN0000017762 TFCP2L1_5
KLF4 TRCN0000005313 KLF4_11*
KLF4 TRCN0000010934 KLF4_15
PKCl/i TRCN0000006037 PKCi1
PKCl/i TRCN0000006040 PKCi4
PKC zeta TRCN0000010114 PKCz7
Empty Vector Control RHS4080
*30 UTR
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Figure S1. Resetting Human PSC, Related to Figure 1
(A) OCT4 expression after withdrawal of DOX. OCT4 mRNA expression was measured by qRT-PCR.
(B) Immunoblotting for ERK1/2 and pERK1/2. Protein was extracted from H9 cells cultured in FGF/KSR or reset in t2iL+Go¨ from a single well of a 6-well plate (13
106 cells). One fifth of the sample was fractionated by SDS electrophoresis, electroblotted and probed with indicated antibodies.
(C) Image of colony forming assay quantified in Figure 1E. Reset H9 cells maintained in t2iL+Go¨ were seeded without ROCKi at 2000 cells/well in 12-well plates in
t2iL+Go¨. FGF receptor inhibitor PD173074 (0.5 mM) or TGF-b/activin receptor inhibitor A83-01 (0.25 mM) were added as indicated. Colonies were stained for
alkaline phosphatase after 7 days.
(D) Transgene-specific qRT-PCR assay. H9 cells harboring DOX-inducible NANOG and KLF2 transgenes were assayed in the indicated culture conditions.
(E) Expression of ground-state transcription factor transcripts. qRT-PCR assay on reset H1 and Shef6 cells.
(F) Immunostaining for ground-state pluripotencymarkers. Conventional and reset H1 and Shef6 cells were stainedwith antibodies against the indicatedmarkers.
Note nuclear localization of TFE3 in reset cells.
Error bars indicate SD.
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Figure S2. Mitochondrial Activity, Related to Figure 3
(A) COX gene expression determined from RNA-seq analysis. Data extracted from sample analysis in Figure 5
(B) Proliferation in low glucose. After single-cell dissociation, 3x104 cells were seeded on 12-well plates and cultured for 7 days in the indicated concentrations of
glucose. ROCKi was added for seeding conventional PSC. Conventional PSC failed to generate colonies. Reset cells are tolerant against low glucose produce
multiple colonies. Scale bars: 200 mM.
Error bars indicate SD.
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BS-seq Sample Sequencing reads Mapping Efficiency (%) Fold coverage
(Genome length
GRCh37.p13)
Conventional hPSC H9 1 163350819 84.9 4.17
Conventional hPSC H9 2 156765441 85.1 4.00
Conventional hPSC H9 3 153635899 84.9 3.92
Reset cells H9 1 154802363 67.1 3.12
Reset cells H9 2 155956363 66.0 3.09
Reset cells H9 3 137626880 65.8 2.72
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Figure S3. Epigenome Analysis, Related to Figure 4
(A) Sequencing coverage of whole-genome bisulfite sequencing libraries.
(B) BS-seq data for methylation at the SOX2 locus in conventional versus reset H9 cultures.
(C) Immunofluorescence staining for H3K9me3 in mouse cells. Images of mouse post-implantation epiblast stem cells (EpiSC) in FGF/activin and mouse ESC in
t2iL. H3K9me3 appears in green and DAPI staining in blue.
(D) Intensity and distribution of H3K9me3. Six cells were selected at random and intensity and distribution of staining were analyzed by Image J. i). Conventional
human PSC in FGF/KSR. ii). Reset cells in t2iL+Go¨. iii). Mouse EpiSC in bFGF/Activin. iv). Mouse ESC in t2iL.
Scale bars, 20 mM.
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Figure S4. Comparative Expression Analysis, Related to Figure 5
(A) Genes contributing to principal components distinguishing reset cells from conventional human PSC. Gene symbols were extracted from the PCA and the
labels scaled relative to the magnitude of variance. Pluripotency regulators are present in the leftmost area defining reset cells, whereas numerous lineage-
specific genes can be found to the right expressed in conventional human PSC cultures.
(B) Platform-specific principal component analysis of RNA-seq data. Data are compared from reset cells, mouse ESC cultured in three different conditions,
conventional human PSC and 3iL samples from Chan et al. Clustering of cell types when applied to a single technology recapitulates the integrated analysis in
Figure 5A.
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Figure S5. Marker Genes Distinguish Reset Cells from Conventional Human PSC and Alternative Protocols, Related to Figure 5
(A) Platform-specific principal component analysis of microarray data from this study and those reported in Gafni et al. Samples were hybridized to the same array
platform to allow for direct comparison. Reset cells (light red) occupy a tight cluster to the right and conventional PSC (dark red) toward the bottom. Cells
described as naive in Gafni et al. (violet) exhibit wide variation and appear unrelated to ground-state cells.
(B) Heatmap comparing the expression of 48 pluripotency and lineage marker genes selected by the International Stem Cell Consortium (Adewumi et al., 2007)
between reset cells, conventional PSC cultures and those reported in Gafni et al., based on Affymetrix Human Gene 1.0 ST data. Reset cells form a distinct,
relatively uniform population with robust expression of pluripotency genes and repression of lineage markers. In contrast, reportedly naive cells from Gafni et al.
display many of the same traits as conventional PSC with mixed expression of lineage markers and significant reduction of key pluripotency regulators. Only
genes for which a difference in expression was observed are displayed (i.e., scaled expression > 1 or < 1 in at least one sample).
(C) Panel of chromatin modification genes associated with DNA methylation and demethylation, histone methylation and acetylation. Expression trends in
ground-state ESC are recapitulated in reset cells, whereas weaker or divergent transcription is evident in PSC cultured in alternative conditions. Expression levels
are scaled relative to conventional PSC samples from each study. Data from different platforms are separated by spaces between bars.
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Figure S6. Functional Interrogation of Transcription Factor Circuitry, Related to Figure 6
(A) shRNA knockdown of TFCP2L1 and KLF4. Knockdown cells and cells transfected with empty vector were maintained by expression of NANOG and KLF2
transgenes in t2iL+DOX. Knockdown was evaluated by qRT-PCR.
(B) Colony formation after shTFCP2L1 knockdown (KD) in FGF/KSR. Parental H9 cells were stably transfected with empty vector or shTFCP2L1 construct and
selected in puromycin. 4000 cells were plated in FGF/KSR with ROCKi in 12-well plates.
(C) Rescue of TFCP2L1 knockdown with mouse Tfcp2l1. Colony formation by shTFCP2L1 knockdown cells transfected with mouse Tfcp2l1 expression vector.
Knockdown cells maintained by DOX induction of NANOG and KLF2 were transfected with a piggyBac mTfcp2l1 expression vector and transfectant pools
established by selection in hygromycin. Cells were then plated at 2000 cells/well in 24-well plates in t2iL+Go¨ without DOX and stained for alkaline phosphatase
after 7 days.
Error bars indicate SD.
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Figure S7. Transcriptome Meta-Analysis, Related to Discussion
(A) Principal component analysis of human and mouse PSC. Expression data were analyzed from conventional and 6i/L/A cultured human PSC (Theunissen
et al.), H9 conventional and reset cells (this study), ground-state ESC cultured in three different conditions (this study), conventional and NHSM cultured human
PSC (Gafni et al.), conventional and 3iL cultured human PSC (Chan et al.) and single cells from human blastocyst ICMs and primary explant cultures (Yan et al.). 6i/
L/A samples share global similarity with reset cells but appear more divergent from mouse ESC.
(B) Comparison of individual human and mouse genes expressed in alternate culture conditions. Data are normalized to expression levels from conventional
human PSC profiled on each platform. Notably, cells cultured in 6i/L/A largely recapitulate expression trends in reset cells and ground-state ESC, but reduced
expression of TET1 and SOX17 and upregulation of DNA methyltransferase DNMT3A and germ cell marker TDRD1 indicate noteworthy differences, potentially
reflecting developmental distinctions in pluripotent stage. Expression levels are scaled relative to conventional PSC samples from each study. Data from different
platforms are separated by spaces between bars.
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Figure S8. Incomplete Conservation between Mouse and Human Esrrb Loci, Related to Discussion
Esrrb locus of the mouse genome showing Nanog, Oct4, Sox2, and Tcf3 binding sites determined by ChIP-seq with sequences homologous to the equivalent
human locus indicated. Signal tracks for ChIP-seq data from Marson et al. (Marson et al., 2008), were obtained from the the ES cell ChIP-seq compendium
(Martello et al., 2012)
(A) Gray rectangle delineates the binding site of Tcf3, Sox2, Oct4 and Nanog in mouse where there is no conserved sequence between mouse and human.
Conserved sequence is shown in red and green.
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Figure S9. Knockdown of aPKC iota/lambda and zeta, Related to Discussion
Two different shRNA vectors, shPKC iota_1 and shPKC iota_4, were used for knockdown of PKC iota/lambda. shPKCzeta_8 was used for knockdown of PKC
zeta. Scale bars: 100 mM.
(A) Brightfield images of shPKC iota KD and shPKC zeta KD cells cultured in t2iL. shPKC iota KD cell retain undifferentiatedmorphology whereas shPKC zeta cells
progressively differentiate.
(B) Knockdown efficiency of each shRNA.
(C) OCT4 expression at passage 10 (KD lines) or 3 (control).
Error bars indicate SD.
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